Crinetics Pharmaceuticals (CRNX) Stock Price
$40.15 0.7%
to add to portfolio
AI Score
-
Alternative
10 -
Fundamental
7 -
Technical
6
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Crinetics Pharmaceuticals, AI stock picks, stock alerts and much more.
CRNX AI Stock Analysis
Financial Performance
Crinetics Pharmaceuticals' financial performance appears to be struggling as indicated by their revenue, gross profit and operating income which all stand at $0. This is a significant decline from the previous year. The company's EBITDA ratio of 0 also indicates that they are not generating any earnings before interest, taxes, depreciation and amortization. The PE ratio stands at -10.74 suggesting that the stock may be overvalued given the negative earnings.
Stock Price
The company's stock price currently stands at $44.05 and has seen an increase of 30.4% in the past month but a decrease of -17% year over year which shows volatility in its performance. The RSI value is currently at 67.68 indicating that it may be nearing overbought territory while its 200-day moving average of $34.26 suggests that it is trading above its long term trend.
Alternative Data Signals
In terms of alternative data signals, Crinetics Pharmaceuticals seems to have positive trends with web traffic increasing significantly both month over month and year over year which could indicate growing interest in the company or its products/services. However, there is a significant decrease in job postings suggesting possible cost-cutting measures or slowdown in growth plans for the company. Employee business outlook remains very positive which could indicate strong internal confidence about future prospects despite external challenges.
Social Media Followers
The number of social media followers across different platforms like Twitter, Instagram and Facebook has been increasing steadily indicating potential increased brand awareness or engagement with customers/users.
Conclusion
In summary, Crinetics Pharmaceuticals' stock presents a mixed picture with some positive signs such as increased web traffic, positive business outlook and growing social media followers but also some concerning signs like poor financial performance and decrease in job postings. Therefore, the AI stock analysis is neutral for Crinetics Pharmaceuticals' stock.
Note: This AI Stock Analysis is based on data as of October 14. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Crinetics Pharmaceuticals (CRNX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Crinetics Pharmaceuticals (CRNX), currently trading at $40.15, will... Sign up to access price prediction.
About CRNX
-
Crinetics Pharmaceuticals, Inc.
-
Symbol
CRNX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
3.8B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$20.83 0.7% |
7 |
 |
Inovio Pharmaceuticals INO |
$2.27 2% |
2 |
 |
Moderna MRNA |
$26.2 2.4% |
4 |
 |
Anavex Life Sciences AVXL |
$8.67 7.3% |
5 |
 |
BridgeBio Pharma BBIO |
$53.38 0.3% |
5 |
News
CRNX Alternative Data
Web Traffic
Crinetics Pharmaceuticals receives an estimated 21912 monthly visitors to crinetics.com.
-
Web Traffic
21912
-
Change from Previous Month
41.1%
-
3 Month Change
77.7%
-
YoY Change
77.7%
Stocktwits Mentions
Crinetics Pharmaceuticals has been mentioned an estimated 4 times on Stocktwits over the last 24 hours.
-
Stocktwits Mentions
4
-
Daily Change
0%
-
1 Month Change
84.6%
Twitter Followers
Crinetics Pharmaceuticals has 1,057 Twitter Followers on its main Twitter (also known as X) account, which is up by 4.8% over the last month.
-
Twitter Followers
1057
-
Daily Change
0%
-
1 Month Change
4.8%
-
3 Month Change
8.3%
-
YoY Change
8.3%
Facebook Engagement
Crinetics Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Followers
40,962 are following Crinetics Pharmaceuticals on LinkedIn, up by 5.5% over the last month.
-
LinkedIn Followers
40962
-
Daily Change
0.2%
-
1 Month Change
5.5%
-
3 Month Change
14.9%
-
YoY Change
14.9%
Job Postings
Crinetics Pharmaceuticals currenly has an estimated 25 open job postings, up by 4.2% over the last month.
-
Job Postings
25
-
Daily Change
0%
-
1 Month Change
4.2%
-
3 Month Change
43.2%
-
YoY Change
43.2%
LinkedIn Employees
According to LinkedIn, Crinetics Pharmaceuticals has 557 employees, up by 3.5% over the last month.
-
LinkedIn Employees
557
-
Daily Change
0%
-
1 Month Change
3.5%
-
3 Month Change
13.2%
-
YoY Change
13.2%
Reddit Mentions
Crinetics Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
Crinetics Pharmaceuticals has 167 Instagram Followers on its main Instagram account, up by 5.7% over the last month.
-
Instagram Followers
167
-
Daily Change
0%
-
1 Month Change
5.7%
-
3 Month Change
5%
-
YoY Change
5%
Business Outlook
According to employee reviews, the business outlook among employees at Crinetics Pharmaceuticals is 90 out of 100 (very bullish).
-
Business Outlook
90
-
Change from Previous Month
1.1%
-
3 Month Change
1.1%
-
YoY Change
1.1%
News Mentions
Crinetics Pharmaceuticals was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
CRNX Financials
CRNX Key Metrics
-
Total Revenue
$0
-
Net Income
-$80.6M
-
Earnings per Share
-$0.88
-
Free cash flow
-$65.7M
-
EBITDA
-$94M
-
EBITDA Ratio
0
-
Total Assets
$1.4B
CRNX 2-year Revenue & Income
CRNX 2-year Free Cash Flow
CRNX Technicals
CRNX SMA
CRNX RSI
FAQ
What's the current price of Crinetics Pharmaceuticals (CRNX) Stock?
The price of an Crinetics Pharmaceuticals (CRNX) share is $40.15.
What's the market cap of Crinetics Pharmaceuticals?
The current market cap of Crinetics Pharmaceuticals is 3.8B.
What are some stocks similar to Crinetics Pharmaceuticals (CRNX) that investors often compare it to?
Crinetics Pharmaceuticals (CRNX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Crinetics Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Crinetics Pharmaceuticals' stock price to be around $43.2 in 2026. Starting from the current price of $40.15, this represents a 7.6% change in price, indicating a bullish outlook for the stock.
How to buy Crinetics Pharmaceuticals (CRNX) Stock?
Crinetics Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Crinetics Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.